**Question:** Caplan syndrome is seen in

A. Systemic lupus erythematosus
B. Gout
C. Rheumatoid arthritis
D. Scleroderma

**Correct Answer:** D. Scleroderma

**Core Concept:** Caplan syndrome is a rare condition characterized by the presence of non-erosive, non-deforming, symmetric joint pain and swelling in patients with systemic sclerosis (scleroderma). It is named after Dr. Robert Caplan who first described the syndrome in 1972.

**Why the Correct Answer is Right:** Caplan syndrome is associated with systemic sclerosis or scleroderma, a chronic autoimmune disease characterized by excessive collagen deposition, leading to skin thickening, and internal organ involvement. In this condition, the immune system mistakenly attacks the body's own tissues, including blood vessels and connective tissues. In Caplan syndrome, the immune system attacks the small blood vessels (capillaries) in the joints, causing inflammation and joint pain and swelling. The symptoms of joint pain and swelling are non-erosive and non-deforming, distinguishing Caplan syndrome from other conditions like rheumatoid arthritis or gout, which present with erosive joint damage and deformity.

**Why Each Wrong Option is Incorrect:**

A. Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by inflammation and immune system dysfunction affecting various organs, but it does not present with joint pain and swelling.

B. Gout is a form of arthritis caused by the buildup of uric acid crystals in the joints, leading to inflammation and pain. It typically affects single joints and presents with a sudden onset of severe pain and swelling.

C. Rheumatoid arthritis is a chronic autoimmune disorder characterized by inflammation of synovial membranes, leading to joint pain, swelling, and deformity. It presents with symmetric involvement of multiple joints, which is different from the asymmetric joint involvement seen in Caplan syndrome.

**Clinical Pearl:** Caplan syndrome is a clinical entity to be considered in the differential diagnosis of joint pain and swelling in patients with systemic sclerosis. Early recognition and differentiation from other conditions like rheumatoid arthritis are essential to initiate appropriate treatment to reduce joint pain and protect against further joint damage. In Caplan syndrome, immunosuppressive therapy might be beneficial in controlling the inflammation in the joints.